Ipsen S.A.
Ipsen S.A. (PAR: IPN) is trading at €143.20, about ₹15,651 at today's EUR/INR rate, as of 29 Sep 2026, 11:35 AM ET, down 0.21% today. Indian residents can buy Ipsen from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€142.70
Today's high
€145.50
52 week low
€112.70
52 week high
€174.00
IPN opened at €144.30, closed previously at €143.50, and has traded between €112.70 and €174.00 over the past 52 weeks.
About
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial for the treatment of second line follicular lymphoma; Tovorafenib that is in phase III clinical trial to treat first line pediatric Low-Grade Gliomas and is In phase II clinical trial for the treatment of relapsed/refractory pediatric Low-Grade Gliomas; and IPN01194 and IPN01195 that is in phase I to treat solid tumors. The company is also developing products for rare disease comprising Bylvay for the treatment of progressive familial intrahepatic cholestasis; Iqirvo, a peroxisome proliferator-activated receptor agonist to treat primary biliary cholangitis; NutropinAq, a liquid formulation of recombinant human growth hormone; Increlex, a recombinant human insulin-like growth factor; Fidrisertib that is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressive; Ritivixibat that is in phase II clinical trial to treat primary sclerosing cholangitis. In addition, it develops neuroscience products, such as Dysport that is in phase III clinical trial for the treatment of chronic and episodic migraine; and IPN10200 that is in phase II to treat aesthetic and therapeutic indications. The company has a partnership with Simcere Zaiming Pharmaceutical Co., Ltd. for the development of SIM0613, a protein expressed on varies tumor types and cancer-associated fibroblasts. The company was founded in 1929 and is headquartered in Paris, France.
Key statistics
Avg. volume
116.59K
Market cap
€11.84B
P/E Ratio
23.10
Price-to-sales ratio
2.93
Enterprise value
€10.83B
Free cash flow yield
10.36%
Debt-to-equity ratio
0.20
Return on equity
11.33%
ROIC
14.87%
Beta
0.32
Dividend yield
1.12%
Last dividend
€1.60
Financial overview
Revenue
€3.68B
Earnings per share
€5.37
Free cash flow
€1.03B
Net profit margin
12.67%
Gross margin
67.52%
EBITDA
€1.10B
Revenue growth
2.84%
Similar securities
This is not an investment recommendation
How to buy Ipsen from India
Indian residents can buy Ipsen shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Ipsen and place an order
Find Ipsen by name or by its ticker, IPN, and choose an order type. Ipsen trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Ipsen position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Ipsen from India
Trading and taxes when buying Ipsen from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Ipsen’s current yield is 1.12%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Ipsen stock?
Yes. Ipsen (IPN) has been listed on Euronext Paris since 2005, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Ipsen share cost in rupees?
One Ipsen share is €143.20 — about ₹15,651 at an EUR/INR rate of 109.29 on 28 Sep 2026. Both the Ipsen price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Ipsen from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Ipsen shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Ipsen price. Paasa issues a capital-gains statement for your return.
Does Ipsen pay a dividend, and how is it taxed in India?
Yes. Ipsen pays a dividend and the current yield is 1.12%; the last declared dividend was €1.60 per share, about ₹174.87. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Ipsen from India?
Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.
Do I have to declare Ipsen shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Ipsen holding, its cost and its closing value.
How do I sell Ipsen and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Ipsen?
Yes. Ipsen is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.